Capsida
About:
Capsida is a biotechnology company that specializes in tackling monogenetic and sporadic CNS and non-CNS disorders.
Website: https://capsida.com
Top Investors: AbbVie, Versant Ventures, Westlake Village BioPartners
Description:
Capsida is a biotechnology company that specializes in tackling monogenetic and sporadic CNS and non-CNS disorders. It features a proprietary adeno-associated virus (AAV) engineering platform that generates capsids optimized to target specific tissues and cells in the diseased organ.
Total Funding Amount:
$140M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Newbury Park, California, United States
Founded Date:
2019-01-01
Founders:
Nicholas Flytzanis, Nick Goeden
Number of Employees:
51-100
Last Funding Date:
2023-02-23
IPO Status:
Private
Industries:
© 2025 bioDAO.ai